4.5 Article

Characterization of the cognitive impairments induced by prenatal exposure to stress in the rat

期刊

出版社

FRONTIERS MEDIA SA
DOI: 10.3389/fnbeh.2010.00173

关键词

gestational stress; schizophrenia; sex differences; adolescence; animal models; cognition

资金

  1. [T32 MH067533]
  2. [K12HD043489]
  3. [MH73826]
  4. [P50 MH082999]

向作者/读者索取更多资源

We have previously shown that male rats exposed to gestational stress exhibit phenotypes resembling what is observed in schizophrenia, including hypersensitivity to amphetamine, blunted sensory gating, disrupted social behavior, impaired stress axis regulation, and aberrant prefrontal expression of genes involved in synaptic plasticity. Maternal psychological stress during pregnancy has been associated with adverse cognitive outcomes among children, as well as an increased risk for developing schizophrenia, which is characterized by significant cognitive deficits. We sought to characterize the long-term cognitive outcome of prenatal stress using a preclinical paradigm, which is readily amenable to the development of novel therapeutic strategies. Rats exposed to repeated variable prenatal stress during the third week of gestation were evaluated using a battery of cognitive tests, including the novel object recognition task, cued and contextual fear conditioning, the Morris water maze, and iterative versions of a paradigm in which working and reference memory for both objects and spatial locations can be assessed (the Can Test). Prenatally stressed males were impaired relative to controls on each of these tasks, confirming the face validity of this preclinical paradigm and extending the cognitive implications of prenatal stress exposure beyond the hippocampus. Interestingly, in experiments where both sexes were included, the performance of females was found to be less affected by prenatal stress compared to that of males. This could be related to the finding that women are less vulnerable than men to schizophrenia, and merits further investigation.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Review Cell Biology

Understanding the Cellular and Molecular Mechanisms of Physical Activity-Induced Health Benefits

P. Darrell Neufer, Marcas M. Bamman, Deborah M. Muoio, Claude Bouchard, Dan M. Cooper, Bret H. Goodpaster, Frank W. Booth, Wendy M. Kohrt, Robert E. Gerszten, Mark P. Mattson, Russell T. Hepple, William E. Kraus, Michael B. Reid, Sue C. Bodine, John M. Jakicic, Jerome L. Fleg, John P. Williams, Lyndon Joseph, Mary Evans, Padma Maruvada, Mary Rodgers, Mary Roary, Amanda T. Boyce, Jonelle K. Drugan, James I. Koenig, Richard H. Ingraham, Danuta Krotoski, Mary Garcia-Cazarin, Joan A. McGowan, Maren R. Laughlin

CELL METABOLISM (2015)

Article Psychiatry

Plasma oxytocin levels predict olfactory identification and negative symptoms in individuals with schizophrenia

Gregory P. Strauss, William R. Keller, James I. Koenig, James M. Gold, Kathryn L. Ossenfort, Robert W. Buchanan

SCHIZOPHRENIA RESEARCH (2015)

Article Psychiatry

Endogenous oxytocin levels are associated with the perception of emotion in dynamic body expressions in schizophrenia

Gregory P. Strauss, William R. Keller, James I. Koenig, Sara K. Sullivan, James M. Gold, Robert W. Buchanan

SCHIZOPHRENIA RESEARCH (2015)

Article Psychiatry

Plasma oxytocin levels predict social cue recognition in individuals with schizophrenia

Gregory P. Strauss, William R. Keller, James I. Koenig, James M. Gold, Katherine H. Frost, Robert W. Buchanan

SCHIZOPHRENIA RESEARCH (2015)

Review Cell Biology

The Science of Vascular Contributions to Cognitive Impairment and Dementia (VCID): A Framework for Advancing Research Priorities in the Cerebrovascular Biology of Cognitive Decline

Roderick A. Corriveau, Francesca Bosetti, Marian Emr, Jordan T. Gladman, James I. Koenig, Claudia S. Moy, Katherine Pahigiannis, Salina P. Waddy, Walter Koroshetz

CELLULAR AND MOLECULAR NEUROBIOLOGY (2016)

Article Cardiac & Cardiovascular Systems

Small Blood Vessels: Big Health Problems?: Scientific Recommendations of the National Institutes of Health Workshop

Francesca Bosetti, Zorina S. Galis, Margaret S. Bynoe, Marc Charette, Marilyn J. Cipolla, Gregory J. del Zoppo, Douglas Gould, Thomas S. Hatsukami, Teresa L. Z. Jones, James I. Koenig, Gerard A. Lutty, Christine Maric-Bilkan, Troy Stevens, H. Eser Tolunay, Walter Koroshetz

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2016)

Article Clinical Neurology

Translational Stroke Research Vision and Opportunities

Francesca Bosetti, James I. Koenig, Cenk Ayata, Stephen A. Back, Kyra Becker, Joseph P. Broderick, S. Thomas Carmichael, Sunghee Cho, Marilyn J. Cipolla, Dale Corbett, Roderick A. Corriveau, Steven C. Cramer, Adam R. Ferguson, Seth P. Finklestein, Byron D. Ford, Karen L. Furie, Thomas M. Hemmen, Costantino Iadecola, Lyn B. Jakeman, Scott Janis, Edward C. Jauch, Karen C. Johnston, Patrick M. Kochanek, Harold Kohn, Eng H. Lo, Patrick D. Lyden, Carina Mallard, Louise D. McCullough, Linda M. McGavern, James F. Meschia, Claudia S. Moy, Miguel A. Perez-Pinzon, Ipolia Ramadan, Sean I. Savitz, Lee H. Schwamm, Gary K. Steinberg, Mary P. Stenzel-Poore, Michael Tymianski, Steven Warach, Lawrence R. Wechsler, John H. Zhang, Walter Koroshetz

STROKE (2017)

Review Clinical Neurology

A common data language for clinical research studies: the National Institute of Neurological Disorders and Stroke and American Academy for Cerebral Palsy and Developmental Medicine Cerebral Palsy Common Data Elements Version 1.0 recommendations

Veronica Schiariti, Eileen Fowler, Joline E. Brandenburg, Eric Levey, Sarah Mcintyre, Theresa Sukal-Moulton, Sharon L. Ramey, Jessica Rose, Susan Sienko, Elaine Stashinko, Laura Vogtle, Robin S. Feldman, James I. Koenig

DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY (2018)

Article Clinical Neurology

Social interaction and social withdrawal in rodents as readouts for investigating the negative symptoms of schizophrenia

Christina A. Wilson, James I. Koenig

EUROPEAN NEUROPSYCHOPHARMACOLOGY (2014)

Article Clinical Neurology

Hypothesis: Presymptomatic treatment of Sturge-Weber Syndrome With Aspirin and Antiepileptic Drugs May Delay Seizure Onset

Alyssa M. Day, Adrienne M. Hammill, Csaba Juhasz, Anna L. Pinto, E. Steve Roach, Charles E. McCulloch, Anne M. Comi, Karen L. Ball, Brian J. Fisher, Jim Koenig, Michael T. Lawton, Warren D. Lo, Douglas A. Marchuk, Daniel K. Miles, Marsha A. Moses, Angus A. Wilfong

PEDIATRIC NEUROLOGY (2019)

Article Psychiatry

Endogenous oxytocin levels are associated with impaired social cognition and neurocognition in schizophrenia

Gregory P. Strauss, Hannah C. Chapman, William R. Keller, James I. Koenig, James M. Gold, William T. Carpenter, Robert W. Buchanan

JOURNAL OF PSYCHIATRIC RESEARCH (2019)

Editorial Material Clinical Neurology

Organizational Update: The NINDS-Sponsored Stroke Preclinical Assessment Network Is Moving to Its Next Stage

Francesca Bosetti, James Koenig, L. Scott Janis, Clinton B. Wright

STROKE (2021)

Article Clinical Neurology

The Stroke Preclinical Assessment Network: Rationale, Design, Feasibility, and Stage 1 Results

Patrick D. Lyden, Francesca Bosetti, Marcio A. Diniz, Andre Rogatko, James Koenig, Jessica Lamb, Karisma A. Nagarkatti, Ryan P. Cabeen, David C. Hess, Pradip K. Kamat, Mohammad B. Khan, Kristofer Wood, Krishnan Dhandapani, Ali S. Arbab, Enrique C. Leira, Anil K. Chauhan, Nirav Dhanesha, Rakesh B. Patel, Mariia Kumskova, Daniel Thedens, Andreia Morais, Takahiko Imai, Tao Qin, Cenk Ayata, Ligia S. B. Boisserand, Alison L. Herman, Hannah E. Beatty, Sofia E. Velazquez, Sebastian Diaz-Perez, Basavaraju G. Sanganahalli, Jelena M. Mihailovic, Fahmeed Hyder, Lauren H. Sansing, Raymond C. Koehler, Steven Lannon, Yanrong Shi, Senthilkumar S. Karuppagounder, Adnan Bibic, Kazi Akhter, Jaroslaw Aronowski, Louise D. McCullough, Anjali Chauhan, Andrew Goh

Summary: Cerebral ischemia and reperfusion lead to neurological disabilities, and developing successful stroke treatments has been challenging. The Stroke Preclinical Assessment Network (SPAN) aims to reduce bias in treatment selection for clinical studies by rigorously assessing candidate treatments across multiple research laboratories. The first stage of SPAN successfully implemented standardized procedures, randomization, and blinded assessment. Subsequent stages will evaluate candidate treatments using aged animals and animals with comorbid conditions.

STROKE (2022)

Article Clinical Neurology

Embracing Heterogeneity in The Multicenter Stroke Preclinical Assessment Network (SPAN) Trial

Andreia Morais, Joseph J. J. Locascio, Lauren H. H. Sansing, Jessica Lamb, Karisma Nagarkatti, Takahiko Imai, Klaus van Leyen, Jaroslaw Aronowski, James I. I. Koenig, Francesca Bosetti, Patrick Lyden, Cenk Ayata, SPAN Investigators

Summary: The Stroke Preclinical Assessment Network (SPAN) is a multicenter preclinical trial platform that uses rodent models of transient focal cerebral ischemia to address translational failure in experimental stroke. In this study, we report the heterogeneity introduced by allowing variations in biological and experimental model variables among the 6 SPAN laboratories and its impact on middle cerebral artery occlusion (MCAo) performance.

STROKE (2023)

Editorial Material Clinical Neurology

Organizational Update: The NINDS Reperfusion Research Pipeline

Clinton B. Wright, Francesca Bosetti, James I. Koenig, L. Scott Janis

STROKE (2023)

暂无数据